These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 6178787)

  • 21. Human leukemia-derived cell lines and clones as models for mechanistic analysis of natural killer cell-mediated cytotoxicity.
    Zarcone D; Tilden AB; Friedman HM; Grossi CE
    Cancer Res; 1987 May; 47(10):2674-82. PubMed ID: 2436754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-activated NK cells trigger monocyte oxidative metabolism.
    Pohajdak B; Gomez JL; Wilkins JA; Greenberg AH
    J Immunol; 1984 Nov; 133(5):2430-6. PubMed ID: 6434630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
    Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR
    J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysis of human B-lymphocyte-derived lymphoma/leukemia cells of established cell lines by interferon-activated natural killer (NK) cells.
    Pattengale PK; Gidlund M; Nilsson K; Sundström C; Orn A; Wigzell H
    Int J Cancer; 1981 Oct; 28(4):459-68. PubMed ID: 6171529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Target cell specificity of human natural killer cells. II. Apparent change with activation.
    MacDougall SL; Shustik C; Sullivan AK
    Cell Immunol; 1986 Dec; 103(2):352-64. PubMed ID: 2433052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced natural killer sensitivity with concomitant clonal selection for cells bearing homogeneously staining regions in the human melanoma cell line MeWo upon induction of differentiation with theophylline.
    Haliotis T; Werkmeister JA; Louwman I; Liao SK; Matthews J; Riopelle R; Pross HF; Holden JJ; White BN; Smith A
    J Natl Cancer Inst; 1984 May; 72(5):991-8. PubMed ID: 6201643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for an early calcium-independent event in the activation of the human natural killer cell cytolytic mechanism.
    Brahmi Z; Bray RA; Abrams SI
    J Immunol; 1985 Dec; 135(6):4108-13. PubMed ID: 3864859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
    Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C
    J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of hydroxyl free radical, but not superoxide, in the cytolytic pathway of natural killer cells. Revision of an earlier hypothesis.
    Duwe AK; Roder JC
    Med Biol; 1984; 62(2):95-100. PubMed ID: 6088913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.
    Bloom ET; Babbitt JT; Kawakami K
    J Immunol; 1986 Jul; 137(1):172-8. PubMed ID: 3711665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells.
    Bridges KR; Smith BR
    J Clin Invest; 1985 Sep; 76(3):913-8. PubMed ID: 2995450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
    Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
    J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL; Roozemond RC; van de Griend RJ
    J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of NK cell-induced cytolysis by thiocarbamide antithyroid drugs.
    Ferguson MM; McDonald FG; Alexander WD
    Immunol Lett; 1985; 11(2):117-20. PubMed ID: 3866747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An exoglycosidase-sensitive triggering site on NK cells which is coupled to transmethylation of membrane phospholipids.
    Kiyohara T; Dennis JW; Boegman RJ; Roder JC
    J Immunol; 1985 Jul; 135(1):659-64. PubMed ID: 3923114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human natural killer cells, activated lymphocyte killer cells, and monocytes possess similar cytotoxic mechanisms.
    Burns GF; Triglia T; Bartlett PF; Mackay IR
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7606-10. PubMed ID: 6608725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural killing (NK) of cytomegalovirus (CMV)-infected fibroblasts: a comparison between two strains of CMV, uninfected fibroblasts, and K562 cells.
    Waner JL; Nierenberg JA
    J Med Virol; 1985 Jul; 16(3):233-44. PubMed ID: 2993494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro cytotoxicity and transplantation protection by autologous natural and activated killer cells against an in vitro transformed tumorigenic fibroblast line. A case study.
    Wilhelm SA; Mukherji B
    J Clin Invest; 1985 Apr; 75(4):1162-8. PubMed ID: 3988936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.